Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 4 fuera de 44 páginas
Examen

Heart Failure Certification (HF‑C) Practice Exam – 2026 Edition Complete practice exam with verified ANSWERS

Document preview thumbnail
Vista previa 4 fuera de 44 páginas

Heart Failure Certification (HF‑C) Practice Exam – 2026 Edition Complete practice exam with verified ANSWERS

Vista previa del contenido

Heart Failure Certification (HF‑C) Practice Exam – 2026
Edition
Complete practice exam with verified ANSWERS



Section 1 – Etiology, Anatomy & Pathophysiology (Q1–20)

1. Which of the following is the most common cause of heart failure in developed countries?

A. Hypertension – important contributor, but second to ischemic disease.

B. Coronary artery disease – correct: ischemic myocardial injury impairs cardiac function.

C. Valvular heart disease – less common etiology in developed nations.

D. Viral myocarditis – uncommon, sporadic cause.

ANSWER: B

2. A patient presents with dyspnea on exertion, orthopnea, and paroxysmal nocturnal dyspnea. Which
type of heart failure is most likely?

A. Right‑sided heart failure – produces systemic congestion (edema, JVD), not pulmonary symptoms.

B. High‑output heart failure – rare hyperdynamic state (anemia, thyrotoxicosis).

C. Left‑sided heart failure – correct: pulmonary venous congestion causes these classic symptoms.

D. Constrictive pericarditis – presents with predominant right‑sided signs.

ANSWER: C

3. Which biomarker is most useful for diagnosing and prognosticating heart failure?

A. Troponin I – marks myocyte injury, not volume overload.

B. CK‑MB – low specificity for heart failure.

C. C‑reactive protein – inflammatory marker, nonspecific.

D. B‑type natriuretic peptide (BNP) – correct: released with ventricular wall stress; correlates with
severity.

ANSWER: D

4. What is the mechanism of action of ACE inhibitors in heart failure?

,A. Increase heart rate – incorrect; heart rate is unchanged or slightly reduced.

B. Block beta‑adrenergic receptors – that is the beta‑blocker mechanism.

C. Decrease afterload and preload by inhibiting angiotensin II formation – correct.

D. Promote sodium retention – opposite of the desired effect.

ANSWER: C

5. The primary function of the left ventricle is to:

A. Receive systemic venous return – function of the right atrium.

B. Pump oxygenated blood to the systemic circulation – correct.

C. Pump blood to the lungs – function of the right ventricle.

D. Drain coronary venous blood – function of the coronary sinus.

ANSWER: B

6. HFrEF is defined by:

A. EF ≥50% with stiff ventricle – describes HFpEF.

B. EF ≤40% with impaired systolic contraction – correct.

C. Normal EF with high output – high‑output failure.

D. Pericardial thickening – constrictive pericarditis.

ANSWER: B

7. The primary defect in HFpEF is:

A. Reduced contractility – feature of HFrEF.

B. Impaired relaxation and diastolic filling – correct.

C. Chronic volume loss – not a mechanism of HFpEF.

D. Acute valve rupture – causes acute regurgitation, not HFpEF.

ANSWER: B

8. The most common cause of right‑sided heart failure is:

A. Pulmonary embolism – causes cor pulmonale but less commonly.

B. Primary pulmonary hypertension – less common cause.

C. Left‑sided heart failure – correct: pressure transmits backward into the right heart.

D. Right ventricular infarction – less common cause.

ANSWER: C

,9. Which elevated hormone in heart failure acts as a beneficial counter‑regulatory (vasodilatory,
natriuretic) hormone?

A. Aldosterone – sodium‑retaining and maladaptive.

B. Antidiuretic hormone – promotes water retention.

C. Angiotensin II – potent vasoconstrictor.

D. B‑type natriuretic peptide – correct: promotes natriuresis and vasodilation, though insufficient.

ANSWER: D

10. Chronic RAAS activation in heart failure leads to:

A. Natriuresis – opposite effect.

B. Vasodilation – opposite effect.

C. Myocardial fibrosis and adverse remodeling – correct.

D. Bradycardia – sympathetic activation causes tachycardia.

ANSWER: C

11. In the failing heart, the Frank‑Starling relationship shows that:

A. Contractility always rises with preload – true only in normal myocardium.

B. Beyond a point, increased preload fails to increase stroke volume – correct.

C. Afterload is the main driver of the curve – incorrect.

D. Heart rate determines the curve – incorrect.

ANSWER: B

12. Chronic volume overload produces which ventricular geometric change?

A. Concentric thickening only – response to pressure overload.

B. Dilated, spherical ventricle (eccentric remodeling) – correct.

C. Normal geometry – incorrect.

D. Isolated right ventricular thinning – incorrect.

ANSWER: B

13. Ejection fraction is calculated as:

A. SV × HR – that is cardiac output.

B. (EDV − ESV) ÷ EDV – correct.

C. CO ÷ BSA – that is cardiac index.

, D. EDV + ESV – meaningless sum.

ANSWER: B

14. A normal left ventricular ejection fraction is approximately:

A. 20–35% – severe systolic dysfunction.

B. <40% – *defines HFrEF.*

C. 50–70% – *correct.*

D. >90% – hyperdynamic state.

ANSWER: C

15. Which condition classically causes high‑output heart failure?

A. Aortic stenosis – pressure overload, low‑output pattern.

B. Severe chronic anemia – correct: persistent hyperdynamic circulation.

C. Coronary artery disease – ischemic low‑output failure.

D. Systemic hypertension – afterload‑related low‑output failure.

ANSWER: B

16. Which chemotherapy agent causes dose‑dependent, usually irreversible cardiomyopathy?

A. Trastuzumab – type II injury, often reversible.

B. Doxorubicin (anthracycline) – correct: type I myocyte necrosis, cumulative dose‑related.

C. Cisplatin – mainly vascular and renal toxicity.

D. Vincristine – mainly neuropathy.

ANSWER: B

17. The most common valvular lesion causing heart failure in the elderly is:

A. Mitral valve prolapse – less common cause.

B. Pulmonic stenosis – rare.

C. Aortic stenosis – correct: pressure overload and diastolic/systolic strain.

D. Tricuspid regurgitation – usually secondary to other disease.

ANSWER: C

18. Which heart failure risk factor is non‑modifiable?

A. Sodium intake – modifiable.

B. Physical inactivity – modifiable.

Información del documento

Subido en
15 de agosto de 2026
Número de páginas
44
Escrito en
2026/2027
Tipo
Examen
Contiene
Preguntas y respuestas
$34.49

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
TUTORWILLIAM
4.7
(88)
Vendido
187
Seguidores
61
Artículos
4634
Última venta
11 horas hace



Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes